Jin Yang Pharmaceutical Co. Ltd (KQ:007370) — Market Cap & Net Worth

$41.44 Million USD · ₩61.15 Billion KRW · Rank #22576

Market Cap & Net Worth: Jin Yang Pharmaceutical Co. Ltd (007370)

Jin Yang Pharmaceutical Co. Ltd (KQ:007370) has a market capitalization of $41.44 Million (₩61.15 Billion) as of May 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22576 globally and #1533 in its home market, demonstrating a 4.10% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jin Yang Pharmaceutical Co. Ltd's stock price ₩4950.00 by its total outstanding shares 12354369 (12.35 Million). Analyse cash efficiency ratio of Jin Yang Pharmaceutical Co. Ltd to see how efficiently the company converts income to cash.

Jin Yang Pharmaceutical Co. Ltd Market Cap History: 2015 to 2026

Jin Yang Pharmaceutical Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $32.38 Million to $41.44 Million (0.89% CAGR).

Index Memberships

Jin Yang Pharmaceutical Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$299.07 Billion	0.01%	#776 of 1384
Kosdaq Composite Index KQ11	$299.07 Billion	0.01%	#776 of 1384

Weight: Jin Yang Pharmaceutical Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Jin Yang Pharmaceutical Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Jin Yang Pharmaceutical Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.00x

Jin Yang Pharmaceutical Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.00x

Jin Yang Pharmaceutical Co. Ltd's market cap is 0.00 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$32.38 Million	$40.15 Billion	-$1.00 Billion	0.00x	N/A
2016	$36.98 Million	$36.13 Billion	-$9.10 Billion	0.00x	N/A
2017	$33.85 Million	$43.45 Billion	-$5.77 Billion	0.00x	N/A
2018	$28.46 Million	$46.86 Billion	$933.15 Million	0.00x	0.03x
2019	$34.12 Million	$47.35 Billion	$1.65 Billion	0.00x	0.02x
2020	$55.09 Million	$48.81 Billion	$3.68 Billion	0.00x	0.01x
2021	$56.22 Million	$62.84 Billion	$9.54 Billion	0.00x	0.01x
2022	$53.27 Million	$76.26 Billion	$12.31 Billion	0.00x	0.00x
2023	$51.83 Million	$94.11 Billion	$12.66 Billion	0.00x	0.00x
2024	$48.73 Million	$113.33 Billion	$29.69 Billion	0.00x	0.00x

Competitor Companies of 007370 by Market Capitalization

Companies near Jin Yang Pharmaceutical Co. Ltd in the global market cap rankings as of May 5, 2026.

Key companies related to Jin Yang Pharmaceutical Co. Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.15

Jin Yang Pharmaceutical Co. Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Jin Yang Pharmaceutical Co. Ltd's market cap moved from $32.38 Million to $ 41.44 Million, with a yearly change of 0.89%.

Year	Market Cap	Change (%)
2026	₩41.44 Million	-1.59%
2025	₩42.11 Million	-13.57%
2024	₩48.73 Million	-5.98%
2023	₩51.83 Million	-2.70%
2022	₩53.27 Million	-5.26%
2021	₩56.22 Million	+2.06%
2020	₩55.09 Million	+61.45%
2019	₩34.12 Million	+19.89%
2018	₩28.46 Million	-15.93%
2017	₩33.85 Million	-8.46%
2016	₩36.98 Million	+14.20%
2015	₩32.38 Million	--

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Jin Yang Pharmaceutical Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$41.44 Million USD
MoneyControl	$41.44 Million USD
MarketWatch	$41.44 Million USD
marketcap.company	$41.44 Million USD
Reuters	$41.44 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$41.44 Million

₩61.15 Billion KRW

Market Cap Rank

#22576 Global

#1533 in Korea

Share Price

₩4950.00

Change (1 day)

+0.20%

52-Week Range

₩4370.00 - ₩6740.00

All Time High

₩9262.22